OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer’s Disease
Caihua Ye, Meng Cheng, Lin Ma, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 19, pp. 21822-21835
Closed Access | Times Cited: 37
Caihua Ye, Meng Cheng, Lin Ma, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 19, pp. 21822-21835
Closed Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 134
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 134
Stimulus‐Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy
Haoyu Yu, Rongyao Gao, Yuxin Liu, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 48
Haoyu Yu, Rongyao Gao, Yuxin Liu, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 48
Oxytocin alleviates cognitive and memory impairments by decreasing hippocampal microglial activation and synaptic defects via OXTR/ERK/STAT3 pathway in a mouse model of sepsis-associated encephalopathy
Junliang Jiang, Yue Zou, Chuantong Xie, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 195-213
Closed Access | Times Cited: 26
Junliang Jiang, Yue Zou, Chuantong Xie, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 195-213
Closed Access | Times Cited: 26
Theranostic nanogels: multifunctional agents for simultaneous therapeutic delivery and diagnostic imaging
Ismail Altinbasak, Yasin Alp, Rana Sanyal, et al.
Nanoscale (2024) Vol. 16, Iss. 29, pp. 14033-14056
Open Access | Times Cited: 11
Ismail Altinbasak, Yasin Alp, Rana Sanyal, et al.
Nanoscale (2024) Vol. 16, Iss. 29, pp. 14033-14056
Open Access | Times Cited: 11
Smart nanogels as promising platform for delivery of drug, gene, and vaccine; therapeutic applications and active targeting mechanism
Fatemeh Farjadian, Soroush Mirkiani, Parisa Ghasemiyeh, et al.
European Polymer Journal (2024) Vol. 219, pp. 113400-113400
Closed Access | Times Cited: 10
Fatemeh Farjadian, Soroush Mirkiani, Parisa Ghasemiyeh, et al.
European Polymer Journal (2024) Vol. 219, pp. 113400-113400
Closed Access | Times Cited: 10
SCGN deficiency is a risk factor for autism spectrum disorder
Zhe Liu, Shuai Tan, Lianyu Zhou, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Zhe Liu, Shuai Tan, Lianyu Zhou, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice
María Clara Sellés, Juliana T.S. Fortuna, Yasmin P.R. de Faria, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106545-106545
Open Access | Times Cited: 21
María Clara Sellés, Juliana T.S. Fortuna, Yasmin P.R. de Faria, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106545-106545
Open Access | Times Cited: 21
Engineered macrophage-biomimetic versatile nanoantidotes for inflammation-targeted therapy against Alzheimer's disease by neurotoxin neutralization and immune recognition suppression
Meng Cheng, Caihua Ye, Chunxiao Tian, et al.
Bioactive Materials (2023) Vol. 26, pp. 337-352
Open Access | Times Cited: 18
Meng Cheng, Caihua Ye, Chunxiao Tian, et al.
Bioactive Materials (2023) Vol. 26, pp. 337-352
Open Access | Times Cited: 18
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Biomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease
Jianjian Chu, Weicong Zhang, Yan Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 100-115
Open Access | Times Cited: 15
Jianjian Chu, Weicong Zhang, Yan Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 100-115
Open Access | Times Cited: 15
The Role of Oxytocin in Alzheimer’s Disease and Its Relationship with Social Interaction
Junpei Takahashi, Daisuke Yamada, Wakana Nagano, et al.
Cells (2023) Vol. 12, Iss. 20, pp. 2426-2426
Open Access | Times Cited: 12
Junpei Takahashi, Daisuke Yamada, Wakana Nagano, et al.
Cells (2023) Vol. 12, Iss. 20, pp. 2426-2426
Open Access | Times Cited: 12
Therapeutic potential of plant-derived natural compounds in Alzheimer’s disease: Targeting microglia-mediated neuroinflammation
Yanyan Shen, Fang Liu, Mingjie Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117235-117235
Closed Access | Times Cited: 4
Yanyan Shen, Fang Liu, Mingjie Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117235-117235
Closed Access | Times Cited: 4
Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access
Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier
Elena Romero‐Ben, Upashi Goswami, Javier Cruz, et al.
Acta Biomaterialia (2025)
Open Access
Elena Romero‐Ben, Upashi Goswami, Javier Cruz, et al.
Acta Biomaterialia (2025)
Open Access
Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective
Hong Zhou, Xiuhua Yin, G. Y. Zhang, et al.
JACS Au (2025)
Open Access
Hong Zhou, Xiuhua Yin, G. Y. Zhang, et al.
JACS Au (2025)
Open Access
Non-Peptidic Natural Products that Target and Modulate Oxytocin and Arginine Vasopressin Receptors: Opportunities and Challenges
Dane F. L. Tregeagle, Catherine Doherty, Timothy B. Callis, et al.
Journal of Pharmacological Sciences (2025)
Open Access
Dane F. L. Tregeagle, Catherine Doherty, Timothy B. Callis, et al.
Journal of Pharmacological Sciences (2025)
Open Access
The Role of Oxytocin in Abnormal Brain Development: Effect on Glial Cells and Neuroinflammation
Marit Knoop, Marie-Laure Possovre, Alice Jacquens, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3899-3899
Open Access | Times Cited: 17
Marit Knoop, Marie-Laure Possovre, Alice Jacquens, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3899-3899
Open Access | Times Cited: 17
Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain
Weikang Luo, Cong Chen, Xin Guo, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
Weikang Luo, Cong Chen, Xin Guo, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
Multi-functional auto-fluorescent nanogels for theranostics
Arti Vashist, Andrea Raymond, Prem P. Chapagain, et al.
Journal of NeuroVirology (2023) Vol. 29, Iss. 3, pp. 252-257
Open Access | Times Cited: 7
Arti Vashist, Andrea Raymond, Prem P. Chapagain, et al.
Journal of NeuroVirology (2023) Vol. 29, Iss. 3, pp. 252-257
Open Access | Times Cited: 7
Nanoformulations targeting Alzheimer's disease
Devesh U. Kapoor, Deepak Sharma, Yashwant Pathak, et al.
Elsevier eBooks (2024), pp. 265-282
Closed Access | Times Cited: 2
Devesh U. Kapoor, Deepak Sharma, Yashwant Pathak, et al.
Elsevier eBooks (2024), pp. 265-282
Closed Access | Times Cited: 2
Nanogel-based drug delivery system as a treatment modality for diverse diseases: Are we there yet?
Brianna Brianna, Ayaz Anwar, Sin‐Yeang Teow, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105224-105224
Closed Access | Times Cited: 4
Brianna Brianna, Ayaz Anwar, Sin‐Yeang Teow, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105224-105224
Closed Access | Times Cited: 4
The Oxytocin Puzzle: Unlocking Alzheimer’s Disease
María Clara Sellés, Maurício M. Oliveira
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 3, pp. 1101-1104
Closed Access | Times Cited: 1
María Clara Sellés, Maurício M. Oliveira
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 3, pp. 1101-1104
Closed Access | Times Cited: 1
Unlocking potential of oxytocin: improving intracranial lymphatic drainage for Alzheimer's disease treatment
Caihua Ye, Shengnan Wang, Lin Niu, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4331-4351
Open Access | Times Cited: 1
Caihua Ye, Shengnan Wang, Lin Niu, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4331-4351
Open Access | Times Cited: 1
Oxytocinergic projection from the hypothalamus to supramammillary nucleus drives recognition memory in mice
Junpei Takahashi, Daisuke Yamada, Wakana Nagano, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294113-e0294113
Open Access | Times Cited: 2
Junpei Takahashi, Daisuke Yamada, Wakana Nagano, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294113-e0294113
Open Access | Times Cited: 2
